FutureTech II Acquisition Stock Quote FTII - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

11.55

Bid

1.02

Ask

11.79

Volume

0.00 Day's Range 0.00

10.52 52 Week Range 12.48

Market Cap

34.125M

Previous Close

11.55

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

2,302

Shares Outstanding

2,954,510

Dividend Yield

PE Ratio

11.72

Earnings Per Share (EPS)

0.99

Revenue

Net Profit

2.91M

FutureTech II Acquisition Corp is a blank check company. FutureTech II Acquisition Corp is a blank check company.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Headquarters

Wilmington, Delaware, USA

Founded

FutureTech II Acquisition Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker FTII. The last closing price for FutureTech II Acquisition was $11.55. Over the last year, FutureTech II Acquisition shares have traded in a share price range of $ 10.52 to $ 12.48.

FutureTech II Acquisition currently has 2,954,510 shares outstanding. The market capitalization of FutureTech II Acquisition is $34.12 million. FutureTech II Acquisition has a price to earnings ratio (PE ratio) of 11.72.

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the “Company”) (NASDAQ: FTII), today announced that it...

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health...

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (Nasdaq: FTIIU) (the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	11.55	11.55	11.55	0	0	CS
4	0.44	3.9603960396	11.11	11.9	10.52	628	11.4396323	CS
12	0.3	2.66666666667	11.25	12.3	10.52	2302	11.45300817	CS
26	0.46	4.14788097385	11.09	12.48	10.52	8234	11.14787681	CS
52	0.45	4.05405405405	11.1	12.48	10.52	8231	11.13237819	CS
156	1.6	16.0804020101	9.95	12.48	9.95	23273	10.53376901	CS
260	1.6	16.0804020101	9.95	12.48	9.95	23273	10.53376901	CS

FTII - Frequently Asked Questions (FAQ)

What is the current FutureTech II Acquisition share price?

The current share price of FutureTech II Acquisition is $ 11.55

How many FutureTech II Acquisition shares are in issue?

FutureTech II Acquisition has 2,954,510 shares in issue

What is the market cap of FutureTech II Acquisition?

The market capitalisation of FutureTech II Acquisition is USD 34.12M

What is the 1 year trading range for FutureTech II Acquisition share price?

FutureTech II Acquisition has traded in the range of $ 10.52 to $ 12.48 during the past year

What is the PE ratio of FutureTech II Acquisition?

The price to earnings ratio of FutureTech II Acquisition is 11.72

What is the reporting currency for FutureTech II Acquisition?

FutureTech II Acquisition reports financial results in USD

What is the latest annual profit for FutureTech II Acquisition?

The latest annual profit of FutureTech II Acquisition is USD 2.91M

What is the registered address of FutureTech II Acquisition?

The registered address for FutureTech II Acquisition is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

Which industry sector does FutureTech II Acquisition operate in?

FutureTech II Acquisition operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Symbol	Price	Vol.
TSVT2seventy bio Inc	$ 4.915 (75.54%)	300.47k
TNONTenon Medical Inc	$ 2.06 (64.80%)	5.08M
TILEInterface Inc	$ 28.00 (49.73%)	262
AWHAspira Womans Health Inc	$ 0.2944 (48.69%)	9.47M
ADTNADTRAN Holdings Inc	$ 11.49 (35.34%)	3
PHATPhathom Pharmaceuticals Inc	$ 2.00 (-54.55%)	105
NEOGNeogen Corporation	$ 6.03 (-39.58%)	8
JANXJanux Therapeutics Inc	$ 20.05 (-33.65%)	13
LZMHLZ Technology Holdings Ltd	$ 12.01 (-23.31%)	7
SNCRSynchronoss Technologies Inc	$ 6.01 (-22.45%)	3
AWHAspira Womans Health Inc	$ 0.2934 (48.18%)	9.49M
BTOGBit Origin Ltd	$ 0.5402 (13.70%)	7.84M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 7.87 (6.64%)	7.06M
CUTRCutera Inc	$ 0.1661 (29.26%)	5.54M
TNONTenon Medical Inc	$ 2.06 (64.80%)	5.08M

Symbol

Price

Vol.

AWHAspira Womans Health Inc

$ 0.2934

(48.18%)

9.49M

BTOGBit Origin Ltd

$ 0.5402

(13.70%)

7.84M

TSLLDirexion Daily TSLA Bull 2X Trust ETF

$ 7.87

(6.64%)

7.06M

CUTRCutera Inc

$ 0.1661

(29.26%)

5.54M

TNONTenon Medical Inc

$ 2.06

(64.80%)

5.08M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

FutureTech II Acquisition Corporation (FTII)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About FutureTech II Acquisition Corporation

Ask ADVFN Intelligence (AI)

FTII Latest News

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FTII - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

FutureTech II Acquisition Corporation (FTII) Quote

FutureTech II Acquisition Corporation (FTII)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About FutureTech II Acquisition Corporation

Ask ADVFN Intelligence (AI)

FTII Latest News

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FTII - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free